“Both nanoencapsulated quercetin and nanoencapsulated DMSA were more effective at decreasing … liver or brain compared to conventional delivery methods, but coencapsulation of quercetin … DMSA into nanoparticles had a marked synergistic effect, decreasing liver and brain arsenic levels … and 4.8μg/g to 2.2 and 1.5μg/g, respectively.”
“We conclude that coencapsulation of quercetin and DMSA may provide a more effective therapeutic strategy in the management of arsenic toxicity and also presents a novel way of combining hydrophilic and hydrophobic drugs into a single delivery system.”